Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® ( Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease

Suhag H Parikh, MD, Joel Brochstein, MD, Paul L. Martin, MD PhD, Mitchell E. Horwitz, MD, Einat Galamidi, MD, Iddo Peleg, MSc, MBA, Uri Goshen, M.MDSc., Aurelie Schwarzbach, MSc, David A. Snyder, PhD, Tony Peled, MSc, Joanne Kurtzberg, MD

Blood (2016) 128 (22): 3651.

https://doi.org/10.1182/blood.V128.22.3651.3651

Published: 2016

Journal Articles

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

Blood (2013) 122 (21): 543.

https://doi.org/10.1182/blood.V122.21.543.543

Published: 2013

Journal Articles

Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd

Suhag H Parikh, MD, Paul L Martin, MD, PhD, Timothy A Driscoll, Jennifer Baker, RN, Ketti Piersol, PNP, Jerelyn Moffet, PNP, Andre Stokhuyzen, PNP, Joanne Kurtzberg, MD, Paul Szabolcs, MD

Blood (2010) 116 (21): 3535.

https://doi.org/10.1182/blood.V116.21.3535.3535

Published: 2010

Journal Articles

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Priti Tewari, MD, Susan Wood, PNP, Paul L Martin, MD, PhD, Suhag H Parikh, MD, Paul Szabolcs, MD, Kristin M Page, MD, Timothy Driscoll, MD, Joanne Kurtzberg, MD, Vinod K. Prasad, MBBS, MD, MRCP,

Blood (2009) 114 (22): 3398.

https://doi.org/10.1182/blood.V114.22.3398.3398

Published: 2009

Journal Articles

Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.

Vinod K. Prasad, MBBS, MD, MRCP, Premjit Gill, MBChB, Richard Vinesett, BS, Suhag H Parikh, MD, Paul Szabolcs, MD, Timothy A Driscoll, MD, Kristin M Page, MD, Susan Wood, PNP, Deborah Semmel, FNP, Paul L Martin, MD, PhD, Joanne Kurtzberg, MD

Blood (2008) 112 (11): 1975.

https://doi.org/10.1182/blood.V112.11.1975.1975

Published: 2008

Journal Articles

Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.

Vinod K. Prasad, MD, MRCP, Adam Medizabal, MS, Suhag H. Parikh, MD, Paul Szabolcs, MD, Timothy A. Driscoll, MD, Kristin Page, MD, Sonali Lakshminarayanan, MBBS, June Allison, Susan Wood, Deborah Semmell, Maria L. Escolar, Paul L. Martin, MD, PhD, Shelly Carter, Joanne Kurtzberg, MD

Blood (2007) 110 (11): 336.

https://doi.org/10.1182/blood.V110.11.336.336

Published: 2007

Journal Articles

Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).

Vinod K. Prasad, MD, MRCP, Juan Wu, MS, Paul L. Martin, MD, PhD, Timothy A. Driscoll, MD, Suhag H. Parikh, MD, Deborah Semmel, FNP, Jerelyn Moffet, PNP, Lauren Stafford, PNP, Ann Shonkwiler, PNP, Shelly Carter, Sc.D, Paul Szabolcs, MD, Joanne Kurtzberg, MD

Blood (2006) 108 (11): 3150.

https://doi.org/10.1182/blood.V108.11.3150.3150

Published: 2006

NARROW

Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® ( Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.

Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.

Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).

Email alerts

ASH Publications

American Society of Hematology

Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® ( Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.

Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.

Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only